A number of 1'-substituted 9-anilinoacridines were evaluated for their activities against promastigote and amastigote forms of Leishmania major and for their toxicities to human Jurkat leukemia cells. Several compounds possessing l'-NH-alkyl substituents produced more than 80% growth inhibition of macrophageinfected L. major amastigotes at or below a concentration of 1 ,uM. l'-Hexylamino-9-anilinoacridine (compound 14) was the least toxic compound to human Jurkat cells, while it retained strong antileishmanial activity. There was a general trend for the more lipophilic compounds to show the greatest antileishmanial activity, whereas 3,6-di-NH2 substitution of the acridine nucleus reduced or eliminated activity. Some structure-activity relationships of the various compounds are discussed.
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The widespread occurrence of leishmaniasis (2) and the limited repertoire of drugs currently capable of treating leishmanial infections without undesirable side effects (18) are spurring efforts to find more effective cures for the disease. There is evidence that some drugs active against bacterial and mammalian DNA topoisomerases II have limited activity against Leishmania donovani (7) and Leishmania mexicana (20) and that two other potent antileishmanial drugs, sodium stibogluconate and ureastilbamine, inhibit DNA topoisomerase I of L. donovani (6) . Also, it was recently reported that a number of aminoacridines have in vitro activity against Leishmania promastigotes (21) . These observations suggested that a more systematic study of DNA topoisomerase inhibitors for their potential activities against trypanosomes, and in particular Leishmania species, would be worthwhile.
Anilinoacridines have successfully been used to target isozymes of mammalian DNA topoisomerase II (3, 14) , and various analogs are clinically effective against some forms of cancer (11, 12) . Therefore, we tested a wide variety of substituted 9-anilinoacridines for their activities against Trypanosoma lewisi (9) and, on the assumption that protozoal DNA topoisomerases would be closely related, the subset of compounds most active against T. lewisi and additional derivatives were screened against L. major. In the present study we identified a small group of compounds that show in vitro activity against macrophage-infected L. major in the concentration range of <0.1 to 1 ,uM. The structures and properties of the range of compounds tested together with data on their activities against L. major and their toxicities to human Jurkat cells are described. The results confirm that it is possible to modify existing anticancer drugs targeted at DNA topoisomerase II and improve their activities and specificities against other organisms, such as trypanosomes, that cause leishmaniasis. Better knowledge of the structure-activity relationships that increase the potencies of drugs against parasite DNA topoisomerases and that decrease their activities against human cells is now being sought to aid in the design of new drugs that are effective against these and other pathogenic parasitic protozoa. * Corresponding author.
MATERIALS AND METHODS
Acridines. The compounds used in the present study were synthesized by condensation of appropriate 9-chloroacridines and substituted anilines under mildly acidic conditions in methanol (19) ; full details will be published elsewhere. Purification was by crystallization of the hydrochloride salts from methanol-ethyl acetate. Purity and characterization were confirmed by thin-layer chromatography, reverse-phase highpressure liquid chromatography, and nuclear magnetic resonance spectroscopy.
Compounds were prepared as 10 mM stock solutions in 50% aqueous ethanol or dimethyl sulfoxide (DMSO) and were stored in the dark at -20°C.
Assessment of antileishmanial effects. Fresh solutions of the drugs were prepared from the stocks for each experiment. The drugs were first diluted to 4 mM in 50% aqueous ethanol. Further dilutions were in N-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-buffered Dulbecco's (DH) medium (Seromed, Munich, Germany) supplemented with 10% fetal bovine serum (FBS; Seromed). Following pilot experiments in which the drugs were tested over a concentration range of 10-3 to 102 ,IM, the compounds were usually assayed at concentrations of 0.1, 0.3, 1, 3, and, for certain experiments, 10 ,uM. Control cultures received ethanol at the same concentration as that present in drugcontaining cultures. Experiments were performed in triplicate.
The toxicities of the drugs were tested on L. major in both its free extracellular (promastigote) and intracellular (amastigote) forms. The parasites were isolated from skin lesions of DBA/2 mice and were propagated as promastigotes on modified NNN medium as described previously (4 vivo testing. We have used this cell line in our laboratory to study the mechanism of action of anticancer drugs targeted at DNA topoisomerase (10) .
RESULTS
Preliminary experiments indicated that exposure of free L. major to several C-1'-substituted 9-anilinoacridines led to a marked inhibition of growth, as measured by 3H-TdR incorporation. This effect was accompanied by decreased parasite motility and viability observed under the microscope. Subsequent experiments compared the efficacies of the drugs against the parasites in their extracellular versus intracellular forms. Cultures of free promastigotes or parasitized macrophages were treated with the same concentrations of drugs for 48 h, after which the effect of the compounds was assessed by measuring 3H-TdR incorporation by the parasites either directly (free promastigotes) or after releasing the microorganisms from their intracellular location with SDS (see Materials and Methods). The structures of the various drugs tested and the biological results are summarized in Table 1 , while Fig. 1 shows that individual drugs that were active against free parasites also displayed activity against the microorganisms inside macrophages and that they were as potent, or more potent, against the intracellular microorganisms than against the extracellular microorganisms. Compound 14 was one of the most active dru s against both free and intracellular parasites. Inhibition of H-TdR incorporation in the intracellular parasites also correlated with the actual disappearance of the microorganisms from macrophages, as observed by microscopic examination of stained preparations (see below), and it is therefore referred to as parasite killing. In no instance did solvent alone show any cytotoxicity for the extracellular or the intracellular microorganisms, or for their host cells, up to the maximum concentration tested, 0.125% (the drugs at 10 ,uM). Extending the duration of exposure to the drugs to 96 h did not increase intracellular parasite killing (data not shown). Therefore, in subsequent experiments cultures of parasitized macrophages were exposed to drugs for 48 h.
Repeated studies of compound 14 indicated the inherent variability of the method normally used to determine antileishmanial activity against leishmania parasites in macrophages. For 10 ,uM were classified as -. These data are shown in Table 1 . The toxicities of the drugs for the macrophages were readily detected by the granular appearance of the cells when viewed under the microscope and the appearance of pyknotic nuclei and dead cells in stained macrophage preparations. The more promising compounds (e.g., compound 14) were toxic to macrophages at concentrations only 10-to 100-fold greater than those required for parasite inhibition. To obtain some measure of the cytotoxicity of the compounds to human cells, monocytic Jurkat leukemia cells in culture were grown with the compounds for 72 h, and the IC50s are recorded in Table   1 .
Infected macrophages treated with one of the more active compounds (compound 14) were also examined by photomicrography (Fig. 3) . This showed that untreated cells were heavily infected with parasites (Fig. 3A) , whereas infection was dramatically reduced in cells treated with 3 ,uM compound 14 for 48 h (Fig. 3C) , with little apparent toxicity to the macrophages. For some compounds (e.g., compounds 16, 18, 19, 31, and 32) which showed toxicity to the macrophages at concentrations just exceeding those effective against L. major, it was not clear whether their apparent antileishmanial activities were due to toxic effects on the host.
DISCUSSION
The effectiveness of certain topoisomerase IT-inhibiting 9-anilinoacridines (e.g., amsacrine; compound 21) as anticancer drugs (1, 17) suggested that modified derivatives of this broad class of compounds might be useful as antiproto- used were effective only at concentrations that were also likely to be toxic to mammalian cells.
The 9-anilinoacridines listed in Table 1 can be divided into several classes on the basis of the substituent at the 1' position. Compounds 1 to 6, which bear an unsubstituted .o 80-1'-NH2 group, contain substituents designed to greatly vary the pKa of the acridine chromophore. However, they show similar (moderate) antileishmanial activity with the single exception of the 3,6-di-NH2 analog (compound 4), which was inactive. Compound 4 was the strongest base (pKa = 10.99), but its inactivity is unlikely to be due to its basicity since the 3-NH2 and 10-methyl (quaternary) analogs (compounds 2 and 3) also have sufficiently high pK,s to be fully cationic at physiological pH. The 3,6-di-NH2 acridine substitution pattern also reduced the toxicity to the mammalian Jurkat leukemia cell line (Table 1) .
With the exception of the 3,6-di-NH2 analog (compound 8), which was inactive, the next class of compounds (compounds 7 to 15), all possessing a mono-substituted 1'-NHR group, showed much greater antileishmanial activity than the 1'-NH2 compounds. Compounds 7 to 15 bore R groups covering a wide range of lipophilicities, and there was a rough trend for lipophilic compounds bearing longer alkyl chains to be the most active. Thus, the pentyl and hexyl compounds (compounds 12 and 14, respectively) showed + + + activity, while the less lipophilic compounds were less effective. There was also a rough trend in the mammalian toxicity data of the 1'-NHR compounds, with potency declining with higher lipophilicities. A comparison of compounds 12 and 13 showed that a 2'-methoxy substituent significantly lowered the toxicity to mammalian cells (as also observed for compounds 20 versus 21) .
The next three compounds (compounds 16 to 18), which contained lipophilic 1'-NHR side chains (when in the neutral form), also possessed a basic center of pK. at ca. 9, which would be charged at physiological pH, thus rendering the side chain very hydrophilic. The fact that these compounds all show significant antileishmanial activity suggests that it is the neutral form of the drugs (a property likely to be important for drug transport) which is the critical factor. However, compounds 19 to 21, bearing hydrophilic but neutral 1' side chains, also retained significant antileishmanial activities. This indicates that physicochemical properties which are likely to govern drug transport properties, such as lipophilicity, are not the only factors that contribute to activity. The high levels of toxicity of these compounds to Jurkat cells were little affected by a 2'-methoxy substituent.
All the compounds discussed so far (compounds 1 to 21), which bear electron-donating 1' substituents containing a free hydrogen, are susceptible to oxidative metabolism and loss of the side chain to form quinoneimines such as compound 22 (13) . However, compound 22 is inactive as an antileishmanial agent; therefore, the ability to form quinoneimines is a potentially undesirable feature for such drugs. For this reason, two series of compounds not susceptible to this metabolic inactivation were also studied. Compounds 23 to 26, with tertiary 1'-NRR side chains, showed significant antileishmanial activity, suggesting that oxidation to quinoneimines is not essential for activity. While compounds 23 and 24 are relatively lipophilic, it is interesting to compare the high activity (+ + +) of the more hydrophilic compound (compound 26) with its relative compound (compound 15) , which shows that the chemical nature of the 1' substituent is also important for activity.
The second set of compounds in which oxidative quinoneimine formation was blocked were the 1'-CH2R derivatives (compounds 27 to 38). The benzylamine derivatives (apart from the primary amine derivative [compound 27 ], which is expected to be rapidly metabolized) showed relatively high antileishmanial activity, even though it was rather hydrophilic (e.g., compared with compounds 12 to 14). Compound 29 was the only 3,6-di-NH2 derivative to show any (albeit low) antileishmanial activity, possibly because of the favorable effect of the more lipophilic side chain. The pKa of the benzylic amine is too low for the compounds to be significantly charged at physiological pH, but this is not true for the longer-chain derivatives (compounds 32 to 37), in which a combination of a side chain with a high pKa (high hydrophilicity) and a primary amine, which could be rapidly metabolized, may have resulted in low activity. The negatively charged acid derivative (compound 38) was inactive, possibly because of poor uptake by the parasites or macrophages.
In conclusion, the results presented above indicate that 9-anilinoacridines possess significant antileishmanial activity against L. major or parasitized macrophages, although some of the drugs showed toxicity to the macrophages at their effective concentrations. Although detailed structure-activity relationships are difficult to discern because of the limited range of structures studied, there is a broad overall trend for lipophilic compounds to show better antileishmanial activity than the hydrophilic diamino derivatives (compounds 4 and 8). There are also indications that specific structural changes (e.g., 2'-methoxy substitution) might improve the therapeutic index. These observations are being pursued.
